These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1725321)
41. Effects of phosphoramidon in endothelial cell cultures on the endogenous synthesis of endothelin-1 and on conversion of exogenous big endothelin-1 to endothelin-1. Corder R; Harrison VJ; Khan N; Anggård EE; Vane JR J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S73-6. PubMed ID: 7510004 [TBL] [Abstract][Full Text] [Related]
42. Local formation and degradation of endothelin-1 in guinea pig airway tissues. Noguchi K; Fukuroda T; Ikeno Y; Hirose H; Tsukada Y; Nishikibe M; Ikemoto F; Matsuyama K; Yano M Biochem Biophys Res Commun; 1991 Sep; 179(2):830-5. PubMed ID: 1898406 [TBL] [Abstract][Full Text] [Related]
43. Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon. Keller PM; Lee CP; Fenwick AE; Atkinson ST; Elliott JD; DeWolf WE Biochem Biophys Res Commun; 1996 Jun; 223(2):372-8. PubMed ID: 8670289 [TBL] [Abstract][Full Text] [Related]
44. Conversion of big endothelin-1 in rat uterus causes contraction mediated by ETA receptors. Rae GA; Calixto JB; D'Orléans-Juste P J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S192-5. PubMed ID: 7509942 [TBL] [Abstract][Full Text] [Related]
45. Attenuation of hemolysate-induced cerebrovascular endothelial cell injury and of production of endothelin-1 and big endothelin-1 by an endothelin-converting enzyme inhibitor. Chang CZ; Winardi D; Lin CL; Kwan AL; Jeng AY; Kassell NF; Howng SL; Lee KS Surg Neurol; 2002; 58(3-4):181-7; discussion 187-8. PubMed ID: 12480208 [TBL] [Abstract][Full Text] [Related]
46. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1. Raoch V; Martinez-Miguel P; Arribas-Gomez I; Rodriguez-Puyol M; Rodriguez-Puyol D; Lopez-Ongil S Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133 [TBL] [Abstract][Full Text] [Related]
47. Pharmacologic evidence for the specificity of the phosphoramidon-sensitive endothelin-converting enzyme for big endothelin-1. Télémaque S; Gratton JP; Claing A; D'Orléans-Juste P J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S85-9. PubMed ID: 7510007 [TBL] [Abstract][Full Text] [Related]
48. Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays. Plumpton C; Kalinka S; Martin RC; Horton JK; Davenport AP Clin Sci (Lond); 1994 Aug; 87(2):245-51. PubMed ID: 7924171 [TBL] [Abstract][Full Text] [Related]
49. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Xu D; Emoto N; Giaid A; Slaughter C; Kaw S; deWit D; Yanagisawa M Cell; 1994 Aug; 78(3):473-85. PubMed ID: 8062389 [TBL] [Abstract][Full Text] [Related]
50. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi. Yap EY; Battistini B; McKay KO Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217 [TBL] [Abstract][Full Text] [Related]
51. Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma. Lebel N; D'Orléans-Juste P; Fournier A; Sirois P Br J Pharmacol; 1996 Jan; 117(1):184-8. PubMed ID: 8825361 [TBL] [Abstract][Full Text] [Related]
52. Arrhythmogenic effects induced by coronary conversion of pulmonary big endothelin to endothelin: aggravation of this phenomenon in heritable hyperlipidemia. Alexiou K; Dschietzig T; Simsch O; Laule M; Hundertmark J; Baumann G; Stangl K J Am Coll Cardiol; 1998 Nov; 32(6):1773-8. PubMed ID: 9822108 [TBL] [Abstract][Full Text] [Related]
53. Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. Plumpton C; Haynes WG; Webb DJ; Davenport AP J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S34-6. PubMed ID: 8587408 [TBL] [Abstract][Full Text] [Related]
54. Detection by bioassay and specific enzyme-linked immunosorbent assay of phosphoramidon-inhibitable endothelin-converting activity in brain and endothelium. Warner TD; Budzik GP; Mitchell JA; Huang ZJ; Murad F J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S19-21. PubMed ID: 1282965 [TBL] [Abstract][Full Text] [Related]
55. Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro. D'Orléans-Juste P; Télémaque S; Claing A Br J Pharmacol; 1991 Oct; 104(2):440-4. PubMed ID: 1797310 [TBL] [Abstract][Full Text] [Related]
56. Endothelin converting enzyme of bovine carotid artery smooth muscles. Hioki Y; Okada K; Ito H; Matsuyama K; Yano M Biochem Biophys Res Commun; 1991 Jan; 174(2):446-51. PubMed ID: 1899566 [TBL] [Abstract][Full Text] [Related]
57. A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11. Corder R; Khan N; Harrison VJ Biochem Biophys Res Commun; 1995 Feb; 207(1):355-62. PubMed ID: 7857289 [TBL] [Abstract][Full Text] [Related]
58. Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney. Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S Hypertension; 1994 Aug; 24(2):227-33. PubMed ID: 8039848 [TBL] [Abstract][Full Text] [Related]
59. Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. OFF. Ohnaka K; Takayanagi R; Nishikawa M; Haji M; Nawata H J Biol Chem; 1993 Dec; 268(35):26759-66. PubMed ID: 8253812 [TBL] [Abstract][Full Text] [Related]
60. Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme. Battistini B; Woods M; O'Donnell LJ; Warner TD; Corder R; Fournier A; Farthing MJ; Vane JR Br J Pharmacol; 1995 Apr; 114(7):1383-90. PubMed ID: 7606342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]